FO
LJPC

FT Options’s La Jolla Pharmaceutical Company LJPC Stock Holding History

FT Options’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$15K Buy
+2,700
New +$86.8K 0.02% 178
2017
Q2 		– Sell
-21,600
Closed -$6K – 337
2017
Q1 		$6K Buy
+21,600
New +$551K 0.01% 244

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FT Options's LJPC Position: Q3 2017 in Review

FT Options opened a new position in La Jolla Pharmaceutical Company (LJPC) in Q3 2017: 4,560 shares worth $159K. The stake represents 0.24% of the portfolio and ranks #77 among its holdings. This is a return to the name: FT Options previously reported a position in LJPC as recently as Q1 2017.

FT Options first reported a position in LJPC in Q1 2017 and has held it in 2 quarters since. The position peaked at $989K in Q1 2017. 95 funds tracked by Wall St. Rank hold LJPC as of Q3 2017.

  • FT Options held 4,560 shares of La Jolla Pharmaceutical Company worth $159K as of Q3 2017.
  • La Jolla Pharmaceutical Company was a new FT Options position in Q3 2017.
  • La Jolla Pharmaceutical Company made up 0.24% of FT Options's portfolio in Q3 2017, its #77 holding.
  • FT Options first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and has held it in 2 quarters since.
  • FT Options's La Jolla Pharmaceutical Company position peaked at $989K in Q1 2017.
  • 95 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.